Seagen Inc. Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Seagen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Seagen Inc. for May 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | WELCH DANIEL G | Director | Grant | A | 0.00 | 3,700 | 0 | 49,219 | 45.5 K to 49.2 K (+8.13 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Simonian Nancy A | Director | Grant | A | 0.00 | 3,700 | 0 | 18,100 | 14.4 K to 18.1 K (+25.69 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | Orwin John A | Director | Grant | A | 0.00 | 3,700 | 0 | 18,100 | 14.4 K to 18.1 K (+25.69 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | LIPPMAN MARC E | Director | Grant | A | 0.00 | 3,700 | 0 | 135,050 | 131.4 K to 135.1 K (+2.82 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | GRYSKA DAVID W | Director | Grant | A | 0.00 | 3,700 | 0 | 41,350 | 37.7 K to 41.4 K (+9.83 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | AKKARAJU SRINIVAS | Director | Grant | A | 0.00 | 3,700 | 0 | 28,505 | 24.8 K to 28.5 K (+14.92 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 66.60 | 9,260 | 616,716 | 9,260 | |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.60 | 3,700 | 246,420 | 40,898,792 | 40.9 M to 40.9 M (+0.01 %) |
| May 23 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 66.60 | 3,700 | 246,420 | 4,888,564 | 4.9 M to 4.9 M (+0.08 %) |
| May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.20 | 10,000 | 102,000 | 0 | |
| May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 10.20 | 10,000 | 102,000 | 0 | |
| May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.20 | 10,000 | 102,000 | 40,895,092 | 40.9 M to 40.9 M (+0.02 %) |
| May 17 2017 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 10.20 | 10,000 | 102,000 | 4,884,864 | 4.9 M to 4.9 M (+0.21 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 9,330 | 96,006 | 31,259 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 993 | 10,218 | 40,589 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.29 | 100 | 1,029 | 41,582 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Option Exercise | M | 10.20 | 4,039 | 41,198 | 0 | |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.47 | 4,039 | 248,277 | 636,435 | 640.5 K to 636.4 K (-0.63 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.20 | 4,039 | 41,198 | 640,474 | 636.4 K to 640.5 K (+0.63 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 61.72 | 9,330 | 575,848 | 636,435 | 645.8 K to 636.4 K (-1.44 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 9,330 | 96,006 | 645,765 | 636.4 K to 645.8 K (+1.47 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 62.82 | 993 | 62,380 | 636,435 | 637.4 K to 636.4 K (-0.16 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 993 | 10,218 | 637,428 | 636.4 K to 637.4 K (+0.16 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Sell | S | 63.92 | 100 | 6,392 | 636,435 | 636.5 K to 636.4 K (-0.02 %) |
| May 09 2017 | SGEN | SEATTLE GENETICS I ... | SIEGALL CLAY B | President and CEO | Buy | M | 10.29 | 100 | 1,029 | 636,535 | 636.4 K to 636.5 K (+0.02 %) |